Login

Camino a la excelencia translates to "Pathway to excellence." 00:10:00

Share On Facebook Share On Twitter

Tomas Cordoba - CEO - MetroGAS

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Wes Edens on Brightline West and the Rise of Passenger Rail Industry |Wes Edens, Co-Founder, Fortress Investment.
00:10:00
Leading with Optimism and a Vision for Global Impact | Roberto Funari, CEO , Alpargatas SA.
00:10:00
The firm try to reverse the effects of climate change|Heidi Lindvall,Co-Founder and General Partner,Pale Blue Dot
00:10:00
Kyle Floyd Discusses Vox Royalty's Approach and Growth in the Royalty Space
00:10:00
Scale needs to be achieved quickly but also correctly|Roseanne Wincek,Co-Founder and Managing Director,Renegade Partners
00:10:00
Greg Foran on Leading Air New Zealand Through Turbulence and His Vision for the Future | Greg Foran, CEO, Air New Zealand Ltd .
00:10:00
The Quincy Institute and America's Foreign Policy|Andrew Bacevich,Professor,Boston University
00:10:00
Krux Revolutionizes Drilling Efficiency with Comprehensive Data Tracking and Analytics
00:00:00
Detecting infectious diseases in high-throughput lab workflows - John Melki, CEO, Genetic Signatures Ltd
00:10:00
Navigating the New Phase of Oil and Gas Investments | Kate Richard, Founder and CEO, Warwick Energy Group.
00:10:00
taken two public and realized over a billion dollars in exits|Gil Elbaz,Founding Partner,TenOneTen Ventures
00:10:00
September 17 Quarterly Economic Update: Insights from Justin Hyland and Will Hickson | Justin Hyland, Managing Director, Hyland Financial Planning.

© 2017 - Neuhu+